KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsShares Outstanding
Ratios

Teva Pharmaceutical Industries (TEVA) Long-Term Debt Issuances: 2009-2023

Historic Long-Term Debt Issuances for Teva Pharmaceutical Industries (TEVA) over the last 5 years, with Mar 2023 value amounting to $2.5 billion.

  • Teva Pharmaceutical Industries' Long-Term Debt Issuances was N/A to $2.5 billion in Q1 2023 from the same period last year, while for Mar 2023 it was $6.9 billion, marking a year-over-year change of. This contributed to the annual value of $2.5 billion for FY2023, which is N/A change from last year.
  • According to the latest figures from Q1 2023, Teva Pharmaceutical Industries' Long-Term Debt Issuances is $2.5 billion, which was up 245,200.00% from -$1.0 million recorded in Q3 2018.
  • In the past 5 years, Teva Pharmaceutical Industries' Long-Term Debt Issuances ranged from a high of $2.5 billion in Q1 2023 and a low of $2.5 billion during Q1 2023.
  • Moreover, its 1-year median value for Long-Term Debt Issuances was $2.5 billion (2023), whereas its average is $2.5 billion.